Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$56.61 - $80.46 $258,254 - $367,058
-4,562 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$86.23 - $125.19 $62,602 - $90,887
726 Added 18.93%
4,562 $424,000
Q4 2020

Feb 09, 2021

BUY
$79.17 - $111.47 $303,696 - $427,598
3,836 New
3,836 $344,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $473M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Donoghue Forlines LLC Portfolio

Follow Donoghue Forlines LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Donoghue Forlines LLC, based on Form 13F filings with the SEC.

News

Stay updated on Donoghue Forlines LLC with notifications on news.